View Mobile Friendly Conference List »

Setting new standards in information exchange for the pharmaceutical and biotech industry


Announcing Immuno-Oncology KOL Panel at the JPM Health Week in San Francisco

  • January 9, 2017

  • We are pleased to announce that the IO360 team at the Conference Forum together with BioPharm Insight are co-presenting a panel discussion on Immuno-Oncology: Filtering the Hype for the Next Wave of Targets along side the JP Morgan HealthCare conference. The panel discussion will take place January 9, 2017 at the Chandran Art Gallery in San Francisco. Following the discussion, there will be a networking reception.


    Panel Discussion: 5:30 – 6:30 pm

    Immuno-Oncology: Filtering the Hype for the Next Wave of Targets

    Key opinion leaders (KOLs) and industry experts address timely issues in the immuno-oncology field including, but not limited to next-generation I/O therapeutics, check point inhibitors, combinations, pricing and reimbursement expectations, and more.



    Axel Hoos, MD, PhD
    SVP Oncology R&D, GSK and Co-Chair, IO360





    Ira Mellman, PhD
    VP, Cancer Immunology, Genentech





    Lindee Goh
    Partner, Tapestry Networks




    Omid Hamid BW

    Omid Hamid, MD
    Chief, Translational Research and Immunotherapy / Director, Melanoma Therapeutics, The Angeles Clinic




    Ramy Ibrahim, MD
    VP and Head of R&D, Parker Institute for Cancer Immunotherapy




    Moderated by:


    Querida Anderson
    Editor-in-Chief, BioPharm Insight


    Reception 6:30 – 8:30 pm


    This is a complimentary limited seating event. RSVP is required. To register, please click here.


    Venue Information
    chandaran-art-gallery-400-x-171Chandran Art Gallery
    459 Geary Street
    San Francisco, CA 94102






    * Please note, the panel portion of the event is expected to sell out so register quickly. More attendance will be open for the networking portion of the event.